Polygenic risk score prediction of antipsychotic dosage in schizophrenia
- 1 February 2016
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 170 (2-3) , 265-270
Abstract
No abstract availableKeywords
Funding Information
- CIHR (MOP-119332)
This publication has 27 references indexed in Scilit:
- Polygenic risk scores in imaging genetics: Usefulness and applicationsJournal of Psychopharmacology, 2015
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up studyPsychological Medicine, 2014
- Power and Predictive Accuracy of Polygenic Risk ScoresPLOS Genetics, 2013
- Fast and accurate genotype imputation in genome-wide association studies through pre-phasingNature Genetics, 2012
- Long-term Antipsychotic Treatment and Brain VolumesArchives of General Psychiatry, 2011
- Accounting for multiple comparisons in a genome-wide association study (GWAS)BMC Genomics, 2010
- International Consensus Study of Antipsychotic DosingAmerican Journal of Psychiatry, 2010
- The role of dopamine in reward and pleasure behaviour – review of data from preclinical researchActa Psychiatrica Scandinavica, 2005
- Dopaminergic dysfunction in alcoholism and schizophrenia – psychopathological and behavioral correlatesEuropean Psychiatry, 2002
- Addiction and schizophreniaEuropean Psychiatry, 2000